Cargando…

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine

Human enterovirus 71 (EV71) is a significant cause of morbidity and mortality from Hand, Foot and Mouth Disease (HFMD) and neurological complications, particularly in young children in the Asia-Pacific region. There are no vaccines or antiviral therapies currently available for prevention or treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwa, Shi-Hsia, Lee, Yock Ann, Brewoo, Joseph N., Partidos, Charalambos D., Osorio, Jorge E., Santangelo, Joseph D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820736/ https://www.ncbi.nlm.nih.gov/pubmed/24244774 http://dx.doi.org/10.1371/journal.pntd.0002538

Ejemplares similares

Adaptation of Enterovirus 71 to Adult Interferon Deficient Mice
por: Caine, Elizabeth A., et al.
Publicado: (2013)

Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice
por: Caine, Elizabeth A., et al.
Publicado: (2015)

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Inactivated enterovirus A71 vaccines and moving forward
por: Shimizu, Hiroyuki
Publicado: (2021)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
por: Chen, Yaping, et al.
Publicado: (2022)

The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China
por: Jiang, Hongchao, et al.
Publicado: (2021)

Cardiopulmonary failure in children infected with Enterovirus A71
por: Hsia, Shao-Hsuan, et al.
Publicado: (2020)

Receptors for enterovirus 71
por: Yamayoshi, Seiya, et al.
Publicado: (2014)

Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial
por: Li, Yan, et al.
Publicado: (2021)

Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys
por: In, Hyun Ju, et al.
Publicado: (2018)

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
por: Strouts, Fiona R., et al.
Publicado: (2016)

Enterovirus 71 Outbreak, Brunei
por: AbuBakar, Sazaly, et al.
Publicado: (2009)

Recombinant Human Enterovirus 71
Publicado: (2004)

The cellular receptor for enterovirus 71
por: Liu, Yue, et al.
Publicado: (2014)

Enterovirus 71 infection and vaccines
por: Yi, Eun-Je, et al.
Publicado: (2017)

Enterovirus A71 Vaccines
por: Li, Mei-Ling, et al.
Publicado: (2021)

Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections
por: Liu, Jiangning, et al.
Publicado: (2020)

The Seroprevalence and Seroincidence of Enterovirus71 Infection in Infants and Children in Ho Chi Minh City, Viet Nam
por: Tran, Chau Bich Nguyen, et al.
Publicado: (2011)

Enterovirus A71 neurologic complications and long-term sequelae
por: Chang, Luan-Yin, et al.
Publicado: (2019)

A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
por: Ambuel, Yuping, et al.
Publicado: (2014)

Cell and tissue tropism of enterovirus 71 and other enteroviruses infections
por: Lin, Jing-Yi, et al.
Publicado: (2014)

Safety and Immunogenicity of a Stable, Cold-Adapted, Temperature-Sensitive/Conditional Lethal Enterovirus A71 in Monkey Study
por: Chua, Kaw Bing, et al.
Publicado: (2021)

COPI Is Required for Enterovirus 71 Replication
por: Wang, Jianmin, et al.
Publicado: (2012)

Seroepidemiology of Human Enterovirus 71, Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2002)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

112 The Development of Enterovirus 71 Vaccine
por: Xiuling, Li, et al.
Publicado: (2014)

Enterovirus 71 infection and neurological complications
por: Lee, Kyung Yeon
Publicado: (2016)

Antivirals and vaccines for Enterovirus A71
por: Lin, Jing-Yi, et al.
Publicado: (2019)

Cellular receptors for enterovirus A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2020)

Adaptation and Virulence of Enterovirus-A71
por: Kobayashi, Kyousuke, et al.
Publicado: (2021)

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate
por: Kingston, Natalie J, et al.
Publicado: (2023)

Human IgG Fc promotes expression, secretion and immunogenicity of enterovirus 71 VP1 protein
por: Xu, Juan, et al.
Publicado: (2016)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Inhibitory Effects of Norwogonin, Oroxylin A, and Mosloflavone on Enterovirus 71
por: Choi, Hwa Jung, et al.
Publicado: (2016)

Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice
por: Mao, Qunying, et al.
Publicado: (2012)

Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice
por: Chang, Junliang, et al.
Publicado: (2015)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Genomic and serologic characterization of enterovirus A71 brainstem encephalitis
por: Leon, Kristoffer E., et al.
Publicado: (2020)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qelqt8aftlfqfi80mg2bcsedfe